Optinose to Present at the 2020 RBC Capital Markets Global Healthcare Virtual Conference

Rhea-AI Summary

Optinose (NASDAQ:OPTN) announced that CEO Peter Miller will deliver a company overview and business update at the 2020 RBC Capital Markets Global Healthcare Virtual Conference on May 19, 2020, at 10:20 a.m. ET. Investors can access a live webcast of the presentation via the Investors page on the Optinose website. A replay will be available for 30 days post-event. Optinose focuses on patients treated by ENT and allergy specialists.

YARDLEY, Pa., May 14, 2020 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that Chief Executive Officer Peter Miller will present a company overview and business update at the 2020 RBC Capital Markets Global Healthcare Virtual Conference on May 19, 2020, at 10:20 a.m. ET.

To listen to a webcast of the presentation live, please visit the Investors page of the Optinose website.

A replay of the webcast will be available for 30 days following the conclusion of the event.

About Optinose
Optinose is a global specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. To learn more, please visit www.optinose.com or follow us on Twitter and LinkedIn.

Optinose Investor Contact
Jonathan Neely
jonathan.neely@optinose.com
267.521.0531

FAQ

When will Optinose CEO Peter Miller present at the RBC Capital Markets Conference?

Peter Miller will present on May 19, 2020, at 10:20 a.m. ET.

How can I watch the Optinose conference presentation?

You can watch the live webcast on the Investors page of the Optinose website.

Will there be a replay of the Optinose presentation?

Yes, a replay will be available for 30 days following the event.

What is the focus area of Optinose as a pharmaceutical company?

Optinose is focused on serving patients treated by ENT and allergy specialists.